United Kingdom (UK) Genomic Medicine Market (2025-2031) | Competitive Landscape, Forecast, Segmentation, Analysis, Value, Companies, Growth, Outlook, Industry, Share, Size & Revenue, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Genomic Medicine Market - Industry Life Cycle

3.4 United Kingdom (UK) Genomic Medicine Market - Porter's Five Forces

3.5 United Kingdom (UK) Genomic Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United Kingdom (UK) Genomic Medicine Market Revenues & Volume Share, By End- User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and adoption of personalized medicine

4.2.2 Technological advancements in genomic sequencing and analysis

4.2.3 Supportive government initiatives and funding for genomic research

4.3 Market Restraints

4.3.1 High cost of genomic testing and treatments

4.3.2 Regulatory challenges and data privacy concerns

4.3.3 Limited availability of skilled professionals in genomic medicine

6.1 United Kingdom (UK) Genomic Medicine Market, By Application

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Oncology, 2021- 2031F

6.1.4 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Cardiology, 2021- 2031F

6.1.5 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Paediatrics, 2021- 2031F

6.1.6 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Endocrinology, 2021- 2031F

6.1.7 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Respiratory Medicine, 2021- 2031F

6.1.8 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Rare Genetic Disorders, 2021- 2031F

6.1.9 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Genomic Medicine Market, By End- User

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Clinics, 2021- 2031F

6.2.4 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Academic Institutions, 2021- 2031F

6.2.5 United Kingdom (UK) Genomic Medicine Market Revenues & Volume, By Research Institutions, 2021- 2031F

7.1 United Kingdom (UK) Genomic Medicine Market Export to Major Countries

7.2 United Kingdom (UK) Genomic Medicine Market Imports from Major Countries

8.1 Percentage increase in the number of genetic tests conducted annually

8.2 Growth in the number of partnerships between healthcare providers and genomics companies

8.3 Rate of incorporation of genomic data in clinical decision-making

8.4 Number of research grants awarded for genomic medicine projects

8.5 Patient satisfaction scores related to genomic testing and treatment experiences

9.1 United Kingdom (UK) Genomic Medicine Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United Kingdom (UK) Genomic Medicine Market Opportunity Assessment, By End- User, 2021 & 2031F

10.1 United Kingdom (UK) Genomic Medicine Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Genomic Medicine Market Competitive Benchmarking, By Operating and Technical Parameters